Gemini Therapeutics Inc

NASDAQ:GMTX 3:59:51 PM EDT

1.75

-0.21 (-10.71%)

Gemini Therapeutics Inc Stock, NASDAQ:GMTX

300 One Kendall Square, 3rd floor, Cambridge, Massachusetts 02139

United States of America

Phone: +1.617.401.4400

Number of Employees:

http://www.geminitherapeutics.com

Description

Gemini Therapeutics, Inc. is a clinical-stage precision medicine company. It is developing novel therapeutic compounds to treat genetically defined, age-related macular degeneration. The company was founded by Johanna Seddon, Paul Barlow and Andrew Herbert on March 3, 2015 and is headquartered in Cambridge, MA.